← Leaderboards
Matthew B. Schabath
H. Lee Moffitt Cancer Ctr & Res Inst
$5,397,368
Attributed
$12,721,800
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,871,799 · 7
By mechanism
U01$10,740,520 · 2
R01$1,338,153 · 1
R56$299,995 · 1
R21$183,244 · 1
U54$159,888 · 1
P30$149,999 · 1
Top collaborators
- Robert J Gillies12 shared
- John J Heine10 shared
- Jae K. Lee3 shared
- David C Christiani2 shared
- Yanhong Liu2 shared
- Rikki Cannioto1 shared
- John L. Cleveland1 shared
- Lauren Cole Peres1 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Susan T Vadaparampil$11,375,059
- Lauren Cole Peres$4,649,275
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsImageBiological MarkersCollaborationsAlgorithmsCohortImaging BiomarkerRadiomicsTextureDiagnosticSubgroupData SetValidationScreening For CancerResourcesScreeningX-Ray Computed TomographyClassificationDatabasesInstitutionBaseFundingPublic Health RelevanceClinical Data
Grant awards (22)
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center$1,322,710
U01 · FY2025 · CA
Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancer$653,786
R01 · FY2025 · CA
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center$1,256,574
U01 · FY2024 · CA
Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancer$684,367
R01 · FY2024 · CA
Radiomic biomarkers for clinical decision support that predict patient outcomes in serous ovarian carcinoma$299,995
R56 · FY2024 · CA
Pilot Project 1: Testing the effectiveness of an intervention to foster cervical cancer screening promotion for Latinx trans men among medical students$75,973
U54 · FY2024 · CA · contact PI
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center$881,620
U01 · FY2023 · CA
Pilot Project 1: Testing the effectiveness of an intervention to foster cervical cancer screening promotion for Latinx trans men among medical students$83,915
U54 · FY2023 · CA · contact PI
Assessing the Efficacy of Sexual Orientation and Gender Identity (SOGI) Data Collection.$149,999
P30 · FY2022 · CA
Moffitt Imaging Biomarker VAlidation Center$467,624
U01 · FY2021 · CA · contact PI
Moffitt Imaging Biomarker VAlidation Center$879,340
U01 · FY2020 · CA · contact PI
Radiomics of NSCLC$627,157
U01 · FY2020 · CA
Moffitt Imaging Biomarker VAlidation Center$918,681
U01 · FY2019 · CA
Radiomics of NSCLC$568,853
U01 · FY2019 · CA
Moffitt Imaging Biomarker VAlidation Center$725,817
U01 · FY2018 · CA
Radiomics of NSCLC$491,968
U01 · FY2018 · CA
Moffitt Imaging Biomarker VAlidation Center$717,012
U01 · FY2017 · CA
Radiomics of NSCLC$583,540
U01 · FY2017 · CA
Moffitt Imaging Biomarker VAlidation Center$706,998
U01 · FY2016 · CA
Radiomics of NSCLC$562,652
U01 · FY2016 · CA
Ethical Issues in Maintaining a Rapid Tissue Donation Program$183,244
R21 · FY2016 · CA · contact PI
Moffitt Imaging Biomarker VAlidation Center$29,974
U01 · FY2016 · CA